Martingale Asset Management L P Albireo Pharma, Inc. Transaction History

Martingale Asset Management L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$18.54 - $37.29 $1,854 - $3,729	100 Added 0.52%	19,407 $385,000
Q4 2021 Feb 11, 2022	BUY	$21.19 - $31.29 $2,119 - $3,129	100 Added 0.52%	19,307 $449,000
Q3 2021 Nov 12, 2021	BUY	$27.36 - $35.98 $317,376 - $417,367	11,600 Added 152.49%	19,207 $599,000
Q2 2021 Aug 13, 2021	BUY	$28.9 - $36.87 $2,890 - $3,686	100 Added 1.33%	7,607 $267,000
Q1 2021 May 13, 2021	BUY	$32.03 - $42.85 $32,254 - $43,149	1,007 Added 15.49%	7,507 $264,000
Q4 2020 Feb 10, 2021	SELL	$31.56 - $42.16 $258,792 - $345,712	-8,200 Reduced 55.78%	6,500 $243,000
Q3 2020 Nov 12, 2020	BUY	$23.19 - $41.61 $340,893 - $611,667	14,700 New	14,700 $490,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.